Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $165
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Rick Wise maintains a Buy rating on Zimmer Biomet Holdings (NYSE:ZBH) and raises the price target from $160 to $165.
May 18, 2023 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Rick Wise maintains a Buy rating on Zimmer Biomet Holdings and raises the price target from $160 to $165.
The news of Stifel maintaining a Buy rating and raising the price target for Zimmer Biomet Holdings (ZBH) is positive for the stock. This indicates that the analyst has a positive outlook on the company's performance and believes the stock price will increase in the short term. As a result, this news is likely to have a positive impact on ZBH's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100